Cite
HARVARD Citation
Wong, A. et al. (n.d.). 2400 Biomarkers of benefit from cetuximab-based therapy in patient-derived esophageal squamous cell carcinoma xenograft models. European journal of cancer. pp. S470-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wong, A. et al. (n.d.). 2400 Biomarkers of benefit from cetuximab-based therapy in patient-derived esophageal squamous cell carcinoma xenograft models. European journal of cancer. pp. S470-. [Online].